Even after years of warnings, millions of older Americans with dementia are still being prescribed risky brain-altering drugs—often with no clear medical justification. Even after years of clinical ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Memantine HCl 7mg, 14mg, 21mg, 28mg; ext-rel caps. Memantine is postulated to exert its therapeutic effect through its action as a low to moderate affinity uncompetitive (open-channel) N-methyl ...
Another earlier memantine trial – the Benefit and Efficacy in Severely Demented patients during Treatment with Memantine (M-Best or 9403) study – enrolled participants with moderately severe AD as ...
Verywell Health on MSN
Current treatment options for Alzheimer's disease
Medically reviewed by Smita Patel, DO Key Takeaways Non-drug approaches should be tried before medications because they don't ...
Lewy body disease is a stealthy and relentless brain disorder that affects memory, movement, and core body functions. It includes dementia with Lewy bodies and Parkinson’s disease, with or without ...
Alzheimer’s disease is a progressive disease that triggers brain cell deterioration. Over time, this makes things like remembering, learning, controlling emotions, and even basic tasks difficult or ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback